1 Min Read
BUDAPEST, Nov 3 (Reuters) - Hungarian drug maker Richter GDRB.BU has acquired German Grunenthal GmbH's oral contraceptive portfolio for a cash purchase price of 236.5 million euros ($329.8 million), Richter said on Wednesday.
"Grunenthal's existing oral contraceptive business represents a strategic fit for Richter to both strengthen its presence in Western European markets and expand its oral contraceptive product portfolio," it said in a statement.
The purchase includes distribution and marketing rights in all markets worldwide where registration approvals have been granted, Richter said. ($1=.7172 Euro) (Reporting by Gergely Szakacs; Editing by Hans Peters)